Mechanisms of Alzheimers disease pathogenesis in SARS CoV2 infection

$311,220P51FY2023ODNIH

Tulane University Of Louisiana, New Orleans LA

Investigators

Linked publications, trials & patents

Paper 39453193 Paper 39436053 Paper 39398995 Paper 39289468 Paper 39164284 Paper 39149452 Paper 39133676 Paper 39131309 Paper 39066335 Paper 39066199 Paper 38942338 Paper 38675952 Paper 38638441 Paper 38617282 Paper 38577492 Paper 38543734 Paper 38528837 Paper 38461051 Paper 38368584 Paper 38135285 Paper 38092883 Paper 38075920 Paper 38039075 Paper 38037590 Paper 38014096 Paper 38014094 Paper 38005994 Paper 37965349 Paper 37961272 Paper 37961145 Paper 37934362 Paper 37925510 Paper 37896817 Paper 37886544 Paper 37871009 Paper 37796819 Paper 37771291 Paper 37766350 Paper 37766343 Paper 37737611 Paper 37734588 Paper 37712216 Paper 37693534 Paper 37689386 Paper 37668388 Paper 37662559 Paper 37658595 Paper 37658590 Paper 37629052 Paper 37628711 Paper 37563642 Paper 37513022 Paper 37497218 Paper 37480292 Paper 37479685 Paper 37457744 Paper 37417740 Paper 37399208 Paper 37398418 Paper 37366075 Paper 37293310 Paper 37279544 Paper 37244986 Paper 37162508 Paper 37153584 Paper 37090643 Paper 37080736 Paper 37073617 Paper 37036007 Paper 37022787 Paper 37012543 Paper 36992502 Paper 36992332 Paper 36992331 Paper 36975141 Paper 36870567 Paper 36865309 Paper 36845143 Paper 36753524 Paper 36753522 Paper 36732510 Paper 36726992 Paper 36726540 Paper 36721163 Paper 36717721 Paper 36680154 Paper 36678479 Paper 36670361 Paper 36650549 Paper 36560823 Paper 36526890 Paper 36526642 Paper 36517984 Paper 36502383 Paper 36377612 Paper 36290956 Paper 36275677 Paper 36210315 Paper 36181356 Paper 36174117

Abstract

PROJECT SUMMARY This application is a supplement request to our P51 base grant to Tulane National Primate Research Center (TNPRC) to further the investigation of the Post-Acute Sequelae of SARS-CoV-2 infection (PASC). This application investigates the overarching hypothesis that SARS-CoV-2-induced dysregulation of metabolic pathways involved in tryptophan metabolism and upregulation of DNER, a potential marker of ongoing neurodegeneration, contributes to Alzheimerâs disease (AD) progression. We hypothesize that these alterations contribute to major pathogenic features of CoVID-19 infection and PASC, particularly neurocognitive disturbances, which have increased prevalence in persons previously infected with SARS-CoV-2. Alterations in the Kyn/Tryp levels are known to accelerate AD. Our published studies have shown that systemic Kyn/Typ levels correlate with the severity of lung pathology in the NHP model of SARS-CoV-2 infection. Our in-vitro studies demonstrate that spike enhances amyloid beta aggregation and neurotoxicity in hippocampal neurons. The studies proposed in Aim 1 will utilize samples from ongoing studies on PASC in African Green monkeys (AGMs). Aim 2 studies will be performed in 5XFAD mice, a well-established AD model, to assess the impact of SARS- CoV-2 Spike subunit S1 to recapitulate in vitro studies that Spike enhances the acceleration of amyloid beta aggregation and plaque formation leading to cognitive impairment. This application leverages our ongoing PASC studies in the African green monkey providing all the necessary samples for this investigation. This application also takes advantage of the CoVID-19 NHP Coordinating Center at TNPRC, where three other Centers and we are engaged in Long-CoVID studies and will deposit our data for further analysis. This application represents a novel inquiry into an exciting hypothesis that may provide new insights into novel and effective therapeutic strategies for SARS-CoV-2 infection and PASC.

View original record on NIH RePORTER →